摘要：The SENTRY Antimicrobial Surveillance Program was initiated in January 1997 and was designed tomonitor the predominant pathogens and antimicrobial resistance for both nosocomial and community-acquired infections globally by using validated, reference-quality identification and susceptibilitytesting methods performed in a central laboratory. Consecutive bacterial or fungal isolates, deemedclinically significant by local criteria, are forwarded to the local reference laboratory from various studyobjectives. The major objectives include blood stream infections, community-acquired respiratory tractinfections (Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis),pneumonias in hospitalised patients, skin and soft tissue infections, and urinary tract isolates fromhospitalised patients. In 2001, special objectives were introduced to examine gastroenteritispathogens and .-haemolytic streptococcal isolates. Over 22 nations participate in SENTRYsurveillance globally. The Women's and Children's Hospital, Adelaide has been the reference centrefor the Asia-Pacific region and South Africa since 1998, and three other Australian institutions, fromBrisbane, Perth, and Adelaide, are part of the global network. All isolates received from our region aretested against up to 29 antimicrobial agents using custom-made broth microdilution panels. The datagenerated from SENTRY allows Australia to compare our antimicrobial resistance patterns and trendswith our regional neighbours
